GPX4 and non-small cell lung carcinoma: The combination of berberine with multiple ferroptosis inducers, including sulfasalazine (SAS), RSL3, FIN56, and dihydroartemisinin (DHA), synergistically suppressed NSCLC by depleting GSH via the p53-dependent SLC7A11-GPX4 pathway.